High‐frequency vibration for the recanalization of guidewire refractory chronic total coronary occlusions |
| |
Authors: | Klaus Tiroch MD Louis Cannon MD Mark Reisman MD Ronald Caputo MD Todd Caulfield MD Richard Heuser MD Greg Braden MD Reginald Low MD Gregg Stone MD Alexandra Almonacid MD Jeffrey J. Popma MD |
| |
Affiliation: | 1. Cardiovascular Division, Department of Internal Medicine, Brigham and Women's Hospital, Boston, Massachusetts;2. Cardiovascular Division, Department of Internal Medicine, Northern Michigan Hospital, Petoskey, Michigan;3. Cardiovascular Division, Department of Internal Medicine, Swedish Medical Center, Seattle, Washington;4. Cardiovascular Division, Department of Internal Medicine, St. Joseph Medical Center, Syracuse, New York;5. Cardiovascular Division, Department of Internal Medicine, Providence St. Vincent's Medical Center, Portland, Oregon;6. Cardiovascular Division, Department of Internal Medicine, St. Joseph's Hospital of Phoenix, Phoenix, Arizona;7. Cardiovascular Division, Department of Internal Medicine, Forsyth Medical Center, Winston‐Salem, North Carolina;8. Cardiovascular Division, Department of Internal Medicine, University of California Davis Medical Center, Davis, California;9. Cardiovascular Division, Department of Internal Medicine, Columbia University Medical Center, New York, New York;10. Cardiovascular Division, Department of Internal Medicine, St. Elizabeth Medical Center, Boston, Massachusetts |
| |
Abstract: | Background: Recanalization of coronary chronic total occlusions (CTOs) remains a clinical challenge, particularly when standard guidewire attempts fail. Objectives: We sought to determine the safety and efficacy of a novel method that used high‐frequency (20 kHz) vibration to fragment occlusive fibrous tissue and facilitate guidewire crossing into the distal vessel. Methods: A total of 125 patients with CTO, who failed at attempts of conventional guidewire recanalization after more than 5 min of fluoroscopy time, were enrolled in the study. The primary efficacy endpoint was the advancement of the CROSSER? catheter through the occlusion and attainment of coronary guidewire positioning in the distal coronary lumen. The primary safety endpoint was the occurrence of death, myocardial infarction, clinical perforation, or target vessel revascularization within the first 30 days. Results: The average fluoroscopy time while delivering the CROSSER catheter was 12.4 min. CROSSER‐assisted guidewire recanalization was achieved in 76 (60.8%) procedures and a final diameter stenosis <50% was obtained in 68 (54.4%) of cases. Major adverse events occurred in 11 (8.8%) patients, lower than the predefined objective performance criteria. Angina frequency and quality of life were improved in patients with successful guidewire recanalization. Conclusions: We conclude that high‐frequency vibration using the CROSSER catheter is a safe and effective therapy for patients with CTO, which are refractory to standard guidewire recanalization. © 2008 Wiley‐Liss, Inc. |
| |
Keywords: | chronic total occlusion coronary stents recanalization device coronary artery disease |
|
|